麻豆传媒

Jennifer Joh, M.D., FACS, is a full-time, dedicated breast surgeon at The Hoffberger Breast Center at Mercy in Downtown Baltimore. Dr. Joh also sees patients at select Mercy Community Physician Sites. Devoted to the care of her breast cancer patients, Dr. Joh offers a specialized focus not provided by most breast centers. As a Board Certified breast cancer doctor with a caring spirit, Dr. Joh treats breast cancer and benign breast conditions with compassion, keeping a patient’s personal concerns a top priority. Dr. Joh’s friendly and energetic personality is appreciated by her patients, who easily recognize that patient care is a true commitment and deep source of fulfillment for her. To her patients, Dr. Joh is approachable and easy to communicate with, making the hurdles of breast disease a little more bearable. Dr. Joh is committed to providing patients with personalized, innovative treatment plans to treat breast diseases. Dr. Joh works with the renowned plastic surgeons at Mercy to offer a full array of breast cancer treatments and breast reconstruction procedures. This team of breast doctors provides an individualized approach to breast surgery so patients are left with a more natural look and shape. With medical training from the renowned H. Lee Moffitt Cancer Center and Research Institute in Florida, Dr. Joh has a leading edge knowledge base of breast cancers and comprehensive breast cancer treatment. A published medical expert, Dr. Joh has received recognition by the Annual Multidisciplinary Symposium on Breast Disease for her research on tumor pathology and by the Annual Peter Cyrus-Rizzo III Scientific Seminar for her research on techniques of sentinel lymph node examinations.

Dr. Lynn Dengel is a board-certified and fellowship-trained surgical oncologist specializing in breast cancer and melanoma. She is an Assistant Professor in the Division of Surgical Oncology at the University of Virginia and practices as a breast and melanoma surgeon at Sentara Martha Jefferson Hospital in Charlottesville, Virginia. Dr. Dengel cares for patients in a robust multidisciplinary fashion, utilizes state of the art technology, incorporates up-to-date research findings and takes time to provide education and counseling to her patients to provide outstanding clinical care. Dr. Dengel is recognized by her peers as an expert in breast disease and melanoma. She serves as a committee member for both the Society of Surgical Oncology and the American Society of Breast Surgeons. She has authored and co-authored several articles in leading peer-reviewed publications, including the Annals of Surgical Oncology, Journal of Clinical Oncology, and Annals of Surgery. Dr. Dengel has received recognition for her outstanding research, including the Conquer Cancer Foundation of ASCO Merit Award, supported by Susan G. Komen for the Cure, and the Harvey Baker Traveling Fellow Award from the Society of Surgical Oncology. Research expertise: Dr. Dengel’s research and expertise include translational studies and clinical trials investigating the immune environment at tumor sites and mechanisms that may bolster innate immune response. She is the Principal Investigator of a clinical trial investigating focused ultrasound ablation combined with immunotherapy in advanced solid tumors. Dr. Dengel also serves as lead investigator in multiple studies investigating patient decision making, specifically aiming to improve the process of shared decision making and decreasing decisional regret for patients considering prophylactic mastectomy. Training and education: Dr. Dengel completed a breast surgery fellowship at Memorial Sloan Kettering Cancer Center in New York after finishing her general surgery residency at the University of Virginia Hospital Medical Center in Charlottesville, VA, where she received the Award of Academic Excellence from the department of surgery. Dr. Dengel received her medical degree from the Georgetown University School of Medicine in Washington D.C. where she graduated cum laude and was elected to the Alpha Omega Alpha medical honor society. Prior to medical school, she received her undergraduate degree from Dartmouth College.

Mehra Golshan, MD, MBA, is a cancer surgeon and a nationally and internationally recognized leader in breast cancer treatment and research. In addition to caring for patients, he serves as Deputy Chief Medical Officer for Surgical Services and Clinical Director of the Breast Cancer Program for the Yale Cancer Center, Smilow Cancer Hospital, and Smilow Cancer Hospital Care Centers. Dr. Golshan also serves as the Executive Vice Chair for Operations in the Department of Surgery and Professor of Surgical Oncology at the Yale School of Medicine. Dr. Golshan is a leader in the research with over 150 peer reviewed publications. He has led numerous Phase I, II and III clinical trials and translational science innovations impacting the treatment options and outcomes for women. He is an innovator in tailoring surgery and therapy for women with early stage breast cancer with funding support from the Breast Cancer Research Foundation and National Institutes of Health. He is the principal investigator of several phase II trials aiming to reduce the need for second surgeries or re-excisions in women with breast cancer, one of which uses innovative image-guided operating room capabilities to capture and remove all residual tumor utilizing MRI and mass spectrometry which is used at Yale’s hybrid operating room. Dr. Golshan prides himself on being an educator having trained and mentored over a hundred breast surgical fellows as well as international surgeons. He has lectured and taught surgeons, trainees and students nationally and internationally in the field of oncology and breast cancer treatment. Dr. Golshan is a Board Member of the National Accreditation Program for Breast Centers (NAPBC), Chair of NAPBC Education Committee, Chair of the American College of Surgeons Committee on Interprofessional Education and Practice, and Chair of the American Society of Breast Surgeons Question of the Week Committee. Dr. Golshan completed his fellowship in breast surgical oncology at Northwestern Memorial Hospital. He earned his Medical Degree from Case Western Reserve University School of Medicine and an MBA at Massachusetts Institute of Technology, Sloan School of Management in Cambridge Massachusetts. Prior to joining Yale, he spent 17 years in Boston at Harvard’s Brigham and Women’s Hospital, Dana Farber Cancer Institute where he was the inaugural and incumbent Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology. He also served as the Director of the Breast Surgical Oncology Fellowship at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital and was an Associate Professor of Surgery at Harvard Medical School. Dr. Golshan’s approach to breast cancer treatment is through a specialized team approach. For each new patient, Smilow brings together a team of medical oncologists, radiation oncologists, reconstruction surgeons, pathologists, genetics, breast imagers, radiologists, program nurses, and a robust clinical research program. “I work closely with so many colleagues dedicated deeply to treating and curing breast cancer who inspire me to be a better physician, scientist, and person every day." Education & Training MBA MIT (2019) Fellow Northwestern Memorial Hospital (2003) Resident Rush Presbyterian St. Luke's Medical Center (2002) MD Case Western Reserve University (1996)

Dr. Greenup is an Associate Professor of Surgery (Oncology) and Chief of Breast Surgical Oncology. She provides coordinated, state-of-the-art care to patients with benign and malignant diseases of the breast as part of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center. Learn more about Dr. Greenup She earned her undergraduate degrees in Zoology and Psychology at the University of Wisconsin, where she also completed a Master of Public Health. She received her medical degree from the Medical College of Wisconsin where she also completed her General Surgery residency, and went on to complete a fellowship as part of The Massachusetts General Hospital, Dana-Farber Cancer Institute and Brigham and Women's Hospital Breast Surgery Fellowship. Prior to joining Yale, Dr. Greenup was an Associate Professor of Surgery and Population Health Sciences at the Duke University School of Medicine and Duke Cancer Institute. There she founded the Duke Breast Cancer Outcomes Research Group, and Core Faculty for the Duke Margolis Center for Health Policy. In 2016, she received the National Institutes of Health Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Award to evaluate how financial costs and burden relate to preference-sensitive decisions for breast cancer surgery. In 2017, she was named the American College of Surgeons and the American Society of Breast Surgeons Health Policy Scholar. Her research focuses on aligning patient-centered care with high-quality, lower cost treatment. She serves on several national committees, including the Alliance in Clinical Oncology Ethics and Value Committees, the American College of Surgeons Cancer Care Delivery Task Force, the American Society of Breast Surgeons Legislative Committee, and the Editorial Board for the Annals of Surgical Oncology. Education & Training MD Medical College of Wisconsin (2009) MPH University of Wisconsin (2009)